Claudia Wiesner

Dr. Claudia Wiesner

Faculty of Chemistry, Leipzig University, Leipzig, Saxony, Germany
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2004 in Bioinformatics
Verified
Journal Article
Closed access
JKJoachim Kopka
Joachim Kopka
NSN. Schauer
N. Schauer
SKS. Krueger
S. Krueger
CWClaudia Wiesner
Claudia Wiesner
BUB. Usadel
B. Usadel
DSDirk Steinhauser
Dirk Steinhauser
Metabolomics, in particular gas chromatography-mass spectrometry (GC-MS) based metabolite profiling of biological extracts, is rapidly becoming one of the cornerstones of functional genomics and systems biology. Metabolite profiling has profound applications in discovering the mode of action of drugs or herbicides, and in unravelling the effect of altered gene expression on metabolism and organism performance in biotechnological applications. As such the technology needs to be available to many laboratories. For this, an open exchange of information is required, like that already achieved for transcript and protein data. One of the key-steps in metabolite profiling is the unambiguous identification of metabolites in highly complex metabolite preparations from biological samples. Collections of mass spectra, which comprise frequently observed metabolites of either known or unknown exact chemical structure, represent the most effective means to pool the identification efforts currently performed in many laboratories around the world. Here we present GMD, The Golm Metabolome Database, an open access metabolome database, which should enable these processes. GMD provides public access to custom mass spectral libraries, metabolite profiling experiments as well as additional information and tools, e.g. with regard to methods, spectral information or compounds. The main goal will be the representation of an exchange platform for experimental research activities and bioinformatics to develop and improve metabolomics by multidisciplinary cooperation. http://csbdb.mpimp-golm.mpg.de/gmd.html Steinhauser@mpimp-golm.mpg.de http://csbdb.mpimp-golm.mpg.de/

1 June 2006 in The Plant Journal
Verified
Journal Article
Open access
PDF file
ASAleksandra Skirycz
Aleksandra Skirycz
MRMichael Reichelt
Michael Reichelt
Meike BurowMeike Burow
Meike Burow
CWClaudia Wiesner
Claudia Wiesner
JRJakub Rolcik
Jakub Rolcik
IWIsabell Witt
Isabell Witt
Summary: Glucosinolates are a group of secondary metabolites that function as defense substances against herbivores and micro‐organisms in the plant order Capparales. Indole glucosinolates (IGS), derivatives of tryptophan, may also influence plant growth and development. In Arabidopsis thaliana, indole‐3‐acetaldoxime (IAOx) produced from tryptophan by the activity of two cytochrome P450 enzymes, CYP79B2 and CYP79B3, serves as a precursor for IGS biosynthesis but is also an intermediate in the biosynthetic pathway of indole‐3‐acetic acid (IAA). Another cytochrome P450 enzyme, CYP83B1, funnels IAOx into IGS. Although there is increasing information about the genes involved in this biochemical pathway, their regulation is not fully understood. OBP2 has recently been identified as a member of the DNA‐binding‐with‐one‐finger (DOF) transcription factors, but its function has not been studied in detail so far. Here we report that OBP2 is expressed in the vasculature of all Arabidopsis organs, including leaves, roots, flower stalks and petals. OBP2 expression is induced in response to a generalist herbivore, Spodoptera littoralis, and by treatment with the plant signalling molecule methyl jasmonate, both of which also trigger IGS accumulation. Constitutive and inducible over‐expression of OBP2 activates expression of CYP83B1. In addition, auxin concentration is increased in leaves and seedlings of OBP2 over‐expression lines relative to wild‐type, and plant size is diminished due to a reduction in cell size. RNA interference‐mediated OBP2 blockade leads to reduced expression of CYP83B1. Collectively, these data provide evidence that OBP2 is part of a regulatory network that regulates glucosinolate biosynthesis in Arabidopsis.

27 June 2008 in Journal of Chemical Ecology
Verified
Journal Article
Closed access
PDF file
BWBen Webster
Ben Webster
TBToby Bruce
Toby Bruce
SDSamuel Dufour
Samuel Dufour
CWClaudia Wiesner
Claudia Wiesner
MBMichael Birkett
Michael Birkett
JPJohn Pickett
John Pickett

22 February 2017 in Nature
Verified
Journal Article
Open access
PDF file
SMSimon J. Moore
Simon J. Moore
SSSven T. Sowa
Sven T. Sowa
CSChristopher Schuchardt
Christopher Schuchardt
EDEvelyne Deery
Evelyne Deery
ALAndrew D. Lawrence
Andrew D. Lawrence
MWMartin J. Warren
Martin J. Warren
Methane biogenesis in methanogens is mediated by methyl-coenzyme M reductase, an enzyme that is also responsible for the utilization of methane through anaerobic methane oxidation. The enzyme uses an ancillary factor called coenzyme F430, a nickel-containing modified tetrapyrrole that promotes catalysis through a methyl radical/Ni(ii)-thiolate intermediate. However, it is unclear how coenzyme F430 is synthesized from the common primogenitor uroporphyrinogen iii, incorporating 11 steric centres into the macrocycle, although the pathway must involve chelation, amidation, macrocyclic ring reduction, lactamization and carbocyclic ring formation. Here we identify the proteins that catalyse the biosynthesis of coenzyme F430 from sirohydrochlorin, termed CfbA–CfbE, and demonstrate their activity. The research completes our understanding of how the repertoire of tetrapyrrole-based pigments are constructed, permitting the development of recombinant systems to use these metalloprosthetic groups more widely.

23 October 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSThore Santel
Thore Santel
GPGabi Pflug
Gabi Pflug
NHNasr Y. A. Hemdan
Nasr Y. A. Hemdan
ASAngelika Schäfer
Angelika Schäfer
MHMarcus Hollenbach
Marcus Hollenbach
GBGerd Birkenmeier
Gerd Birkenmeier
Glyoxalases (Glo1 and Glo2) are involved in the glycolytic pathway by detoxifying the reactive methylglyoxal (MGO) into D-lactate in a two-step reaction using glutathione (GSH) as cofactor. Inhibitors of glyoxalases are considered as anti-inflammatory and anti-carcinogenic agents. The recent finding that various polyphenols modulate Glo1 activity has prompted us to assess curcumin's potency as an Glo1 inhibitor. Cultures of whole blood cells and tumor cell lines (PC-3, JIM-1, MDA-MD 231 and 1321N1) were set up to investigate the effect of selected polyphenols, including curcumin, on the LPS-induced cytokine production (cytometric bead-based array), cell proliferation (WST-1 assay), cytosolic Glo1 and Glo2 enzymatic activity, apoptosis/necrosis (annexin V-FITC/propidium iodide staining; flow cytometric analysis) as well as GSH and ATP content. Results of enzyme kinetics revealed that curcumin, compared to the polyphenols quercetin, myricetin, kaempferol, luteolin and rutin, elicited a stronger competitive inhibitory effect on Glo1 (Ki = 5.1±1.4 µM). Applying a whole blood assay, IC50 values of pro-inflammatory cytokine release (TNF-α, IL-6, IL-8, IL-1β) were found to be positively correlated with the Ki-values of the aforementioned polyphenols. Moreover, whereas curcumin was found to hamper the growth of breast cancer (JIMT-1, MDA-MB-231), prostate cancer PC-3 and brain astrocytoma 1321N1 cells, no effect on growth or vitality of human primary hepatocytes was elucidated. Curcumin decreased D-lactate release by tumor cells, another clue for inhibition of intracellular Glo1. The results described herein provide new insights into curcumin's biological activities as they indicate that inhibition of Glo1 by curcumin may result in non-tolerable levels of MGO and GSH, which, in turn, modulate various metabolic cellular pathways including depletion of cellular ATP and GSH content. This may account for curcumin's potency as an anti-inflammatory and anti-tumor agent. The findings support the use of curcumin as a potential therapeutic agent.

1 April 2003 in Journal of Chromatography A
Verified
Journal Article
Closed access
CWClaudia Wiesner
Claudia Wiesner
AKAnia Kolasa
Ania Kolasa
JKJoachim Kopka
Joachim Kopka